| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.7% | 0.0% |
| Div Cover | 9.5 | n/a |
| Op Mrgn | 6.7% | n/a |
| ROCE | 17.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 15.2 | n/a |
| PEG | 2.2 | n/a |
| Pr/Revenue | 1.2 | n/a |
| Pr/Book | 3.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 5.9% | n/a |
| PBT | -1.8% | n/a |
| EPS | 6.9% | n/a |
| DPS | 5.9% | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-22 | 554.20 | 36.00 | 85.80p | 19.3 | 1.4 | +14% | 7.00p | 0.4% |
| 30-Jun-23 | 588.90 | 60.70 | 98.90p | 20.0 | 1.3 | +15% | 7.50p | 0.4% |
| 30-Jun-24 | 638.70 | 35.20 | 83.30p | 12.1 | n/a | -16% | 8.00p | 0.8% |
| 30-Jun-25 | 673.20 | 32.60 | 80.10p | 15.6 | n/a | -4% | 8.50p | 0.7% |
| 30-Jun-26 | 712.80 | 32.00 | 85.60p | 13.7 | 2.0 | +7% | 9.00p | 0.8% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Transaction in Own Shares | 28-Sep-2026 | 07:00 | RNS |
| PDMR Dealing | 24-Sep-2026 | 16:25 | RNS |
| Final results for the year ended 30 June 2026 | 24-Sep-2026 | 07:00 | RNS |
| Vet chain’s £40m for acquisitions | 22-Dec-2011 | The Scotsman |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1,251.00p |
| Change Today | 43.00p |
| % Change | 3.56 % |
| 52 Week High | 1,424.00 |
| 52 Week Low | 1,114.00 |
| Volume | 311,640 |
| Shares Issued | 67.62m |
| Market Cap | £845.87m |
| Beta | 0.00 |
| RiskGrade | 136 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 07-Nov-26 | 06-Nov-25 |
| Paid | 04-Dec-26 | 05-Dec-25 |
| Amount | 9.00p | 8.50p |
| Time | Volume / Share Price |
| 10:00 | 44 @ 1,251.00p |
| 10:00 | 154 @ 1,251.00p |
| 10:00 | 150 @ 1,251.00p |
| 09:54 | 20,000 @ 1,250.00p |
| 09:54 | 1,700 @ 1,250.00p |
| CEO | Richard Fairman |
| Finance Director | Robin Alfonso |
You are here: research